🇺🇸 FDA
Pipeline program

bivalent enterovirus vaccine (Vero cell), inactivated

PRO-EV71CA16-3001

Phase 3 mab active

Quick answer

bivalent enterovirus vaccine (Vero cell), inactivated for Hand, Foot, and Mouth Disease(HFMD) is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Hand, Foot, and Mouth Disease(HFMD)
Phase
Phase 3
Modality
mab
Status
active

Clinical trials